Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sonic Healthcare Limited ( (AU:SHL) ) just unveiled an announcement.
Sonic Healthcare Limited announced a change in the director’s interest, with Director Suzanne Crowe acquiring 2,365 fully paid ordinary shares through an on-market purchase. This change reflects an increase in indirect holdings, potentially indicating confidence in the company’s future performance and stability, which may positively influence stakeholder perception.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$24.00 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily providing laboratory and radiology services. The company focuses on delivering high-quality diagnostic services across various markets, establishing itself as a key player in the global healthcare sector.
Average Trading Volume: 1,425,563
Technical Sentiment Signal: Sell
Current Market Cap: A$10.45B
For detailed information about SHL stock, go to TipRanks’ Stock Analysis page.